Peter Lawson
Stock Analyst at Barclays
(3.7)
Main Sectors:
45 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ONC BeOne Medicines | Initiates Coverage On: Overweight | 385 | 343.87 | 11.96% | 1 | Sep 18, 2025 | |
IDYA IDEAYA Biosciences | Initiates Coverage On: Overweight | 40 | 27.64 | 44.72% | 1 | Sep 4, 2025 | |
SDGR Schrodinger | Initiates Coverage On: Overweight | 25 | 20.59 | 21.42% | 1 | Aug 14, 2025 | |
REPL Replimune Group | Downgrades: Equal-Weight | 17 3 | 4.73 | -36.58% | 4 | Jul 23, 2025 | |
EXEL Exelixis | Maintains: Equal-Weight | 29 40 | 40.09 | -0.22% | 6 | Jul 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 8 3 | 1.78 | 68.54% | 9 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 2 | 1.21 | 65.29% | 4 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | n/a | n/a | 3 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 10 | 6.38 | 56.74% | 3 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 4 | 2.34 | 70.94% | 7 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 22 6 | 11.77 | -49.02% | 2 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 11 | 9.57 | 14.94% | 1 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 16 | 9.61 | 66.49% | 8 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 15 | 8.37 | 79.21% | 2 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 63 47 | n/a | n/a | 4 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 29 14 | 13.36 | 4.79% | 7 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 3 | 2.15 | 39.53% | 5 | Apr 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 3 | 2.11 | 42.18% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 4 | 1.35 | 196.3% | 1 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 54 60 | 46.71 | 28.45% | 3 | Sep 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 17 | 5.48 | 210.22% | 5 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 33 | 15.6 | 111.54% | 4 | Aug 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 5 | n/a | n/a | 4 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 92 66 | 34.21 | 92.93% | 2 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 105 | n/a | n/a | 10 | Jul 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 31 | 9.38 | 230.49% | 2 | Jul 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 13 | 7.76 | 67.53% | 1 | May 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 9 26 | n/a | n/a | 6 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 27 31 | n/a | n/a | 6 | Dec 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 1.47 | 240.14% | 4 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 175 50 | n/a | n/a | 2 | Aug 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 4 | 3.3 | 6.06% | 4 | Jul 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 355 365 | 102.12 | 257.42% | 1 | Aug 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 46 | 40.5 | 13.58% | 2 | Oct 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | n/a | n/a | 1 | May 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 450 | 60.55 | 643.19% | 1 | Mar 4, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 33 | n/a | n/a | 1 | Mar 4, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 65 75 | n/a | n/a | 2 | Dec 4, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 49 | n/a | n/a | 1 | May 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | n/a | n/a | 1 | Apr 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 5 | n/a | n/a | 4 | Apr 9, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 45 | 67.74 | -33.57% | 2 | Jan 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 17 45 | 3.92 | 1047.96% | 2 | Jan 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Jan 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | n/a | n/a | 1 | Jul 14, 2017 |